https://newsroom.astellas.com/ https://newsroom.astellas.com/2026-05-19-astellas-to-present-data-on-long-term-outcomes-and-clinical-use-of-its-portfolio-across-disease-stages-at-asco-2026 Mon, 18 May 2026 19:30:00 -0400 https://newsroom.astellas.com/2026-05-19-astellas-to-present-data-on-long-term-outcomes-and-clinical-use-of-its-portfolio-across-disease-stages-at-asco-2026 https://newsroom.astellas.com/2026-05-15-notice-regarding-continuation-of-the-performance-linked-stock-compensation-scheme-and-performance-linked-stock-delivery-scheme-for-the-domestic-and-global-astellas-group-executives Thu, 14 May 2026 22:30:00 -0400 https://newsroom.astellas.com/2026-05-15-notice-regarding-continuation-of-the-performance-linked-stock-compensation-scheme-and-performance-linked-stock-delivery-scheme-for-the-domestic-and-global-astellas-group-executives https://newsroom.astellas.com/2026-05-15-notice-regarding-continuation-of-the-performance-linked-stock-compensation-scheme Thu, 14 May 2026 22:30:00 -0400 https://newsroom.astellas.com/2026-05-15-notice-regarding-continuation-of-the-performance-linked-stock-compensation-scheme https://newsroom.astellas.com/2026-05-15-chinas-nmpa-accepts-ndapplication-for-izervay-for-the-treatment-of-geographic-atrophy-secondary-to-age-related-macular-degeneration Thu, 14 May 2026 19:30:00 -0400 https://newsroom.astellas.com/2026-05-15-chinas-nmpa-accepts-ndapplication-for-izervay-for-the-treatment-of-geographic-atrophy-secondary-to-age-related-macular-degeneration https://newsroom.astellas.com/2026-05-14-astellas-submits-supplemental-new-drug-application-in-japan-for-padcev-plus-keytruda-in-cisplatin-eligible-patients-with-mibc Thu, 14 May 2026 02:00:00 -0400 https://newsroom.astellas.com/2026-05-14-astellas-submits-supplemental-new-drug-application-in-japan-for-padcev-plus-keytruda-in-cisplatin-eligible-patients-with-mibc